3881 results for «2020»
3881 results
TAVI complications
16 Feb 2019 – From PCR Tokyo Valves 2019
Consult this session to discover through challenging cases how to manage TAVI complications, such as coronary embolism, papillary muscle rupture, and more!
Hot topics in the pharmacologic treatment after TAVI – Current concepts
16 Feb 2019 – From PCR Tokyo Valves 2019
Consult this session to learn more about the risk of valve thrombosis, thrombo-embolic and bleeding events after TAVI and the rationale of antithrombotic treatment regimens in atrial fibrillation patients post TAVI.
Simplified self expandable TAVI implantation for predictable, repeatable outcomes
17 Feb 2019 – From PCR Tokyo Valves 2019
Consult this session to learn more about how to simplify Evolut implantation procedure, and discover some new Evolut implantation techniques.
TAVI and mitral interventions
17 Feb 2019 – From PCR Tokyo Valves 2019
Consult this session to discover challenging TAVI and mitral interventions, such as: bioprosthetic valve fracture, concomitant off-pump beating heart mitral repair and LAA closure, annulus rupture immediately after balloon-expandable transcatheter heart valve implantation, and more!
Prosthesis-patient mismatch after TAVI – what is the impact?
17 Feb 2019 – From PCR Tokyo Valves 2019
Consult this session to learn more about the impact regarding Prosthesis-Patient Mismatch after TAVI, the possible TAVI risks in small anatomy patients, and discover the options to prevent PPM after TAVI.
Excellent abstracts from Japan
17 Feb 2019 – From PCR Tokyo Valves 2019
Consult this session in English and Japanese to learn more about various TAVI studies and cases, regarding topics such as comparison between self- and balloon- expandable valve, clinical outcomes of the 20mm SAPIEN 3, single proglide vascular preclose technique, and more!
TAVI complications: CoreValve
16 Feb 2019 – From PCR Tokyo Valves 2019
Consult this session to discover from various CoreValve cases associated with complications, how to bail out the trouble of the broken delivery system of self-expandable prosthesis, how to cross a degenerated surgical heart valve in a TAV-in-SAV case with the snare technique, and more!
TAVI and other structural interventions
16 Feb 2019 – From PCR Tokyo Valves 2019
Consult this session to discover various TAVI and other structural interventions cases and studies, and learn more about the role of procedural simulation with patient-specific 3D-printed aortic root models, the prognostic value of tricuspid valve geometry and leaflet coaptation status in patients undergoing tricuspid annuloplasty, and more!
TAVI: coronary complications
16 Feb 2019 – From PCR Tokyo Valves 2019
Consult this session to learn more about various TAVI complications, and how to manage them: coronary obstruction, thrombotic occlusion, hemolytic anemia, and more!
MitraClip and other mitral procedures
16 Feb 2019 – From PCR Tokyo Valves 2019
Consult this session to discover various compelling mitral interventions, such as transcatheter edge-to-edge repair for acute mitral regurgitation after ACS with cardiogenic shock, unexpected ST elevation during Cardioband for mitral valve, acute hypoxia requiring iatrogenic atrial septal defect closure, and more!
Left ventricular and systolic dimension determines anatomic suitability for transcatheter mitral valve implantation
25 Jun 2020 – From PCR e-Course 2020
A common exclusion for transcatheter mitral valve implantation (TMVI) is a small predicted neo-left ventricular outflow tract (LVOT). Simulation of the neoLVOT is time-consuming, requires multi-detector computerised tomography (MDCT), specialised software, and computer models of the prosthesis. Measurements that do not require neoLVOT simulation may provide...
New TMVI therapy to eliminate mitral regurgitation. Evidence and patient selection
26 Jun 2020 – From PCR e-Course 2020
Watch this video if you want to get the latest update on the first commercially available TMVI therapy (Tendyne), to learn about Tendyne clinical experience and how to identify the best candidates for this novel therapy.
Two-year outcomes of Tendyne Transcatheter Mitral Valve Implementation (TMVI) to treat symptomatic severe mitral regurgitation
Learn more about the 2-year outcomes of the first 100 patients treated as part of the Tendyne Expanded Clinical Study, and how the latest Tendyne clinical evidence may change the way the heart team treats mitral regurgitation.
Videos included on this page: the Hot Line presentation and...
Portico FlexNav - Optimise TAVI outcomes from routine to complex cases
Watch this session if you want to learn how Portico enables you to achieve favorable haemodynamics and patient outcomes, to learn about the new Portico with FlexNav TAVI system and its deliverability and to learn the importance of looking ahead during transcatheter aortic valve implantation and...
Shaping care pathways for severe aortic stenosis patients in a COVID-19 context
Watch this roundtable discussion on the management of aortic stenosis in the context of the COVID-19 pandemic and how to readdress the treatment options and pathways to serve the needs of the patients in this difficult global crisis.
PCR e-Course Hot lines: drugs and devices for STEMI management
Watch this session to know more about ultrathin-strut vs thin-strut DES in patients with STEMI undergoing percutaneous coronary intervention (BIOSTEMI), RCT between bioresorbable and durable polymer stent by serial OCT assessment (MECHANISM-AMI), and the results of the FUNCOMBO trial.
PICSO improves coronary microvascular function in patients with STEMI
25 Jun 2020 – From PCR e-Course 2020
Watch this video if you want to learn about the latest OxAMI-PiCSO study clinical results and to learn about the first-in-man of PiCSO in inferior STEMI patients.
Videos included on this page: the Hot Line presentation, an Investigator Perspective and a Wrap Up discussion.
Controversies in antiplatelet therapy for secondary prevention of coronary artery events
26 Jun 2020 – From PCR e-Course
Watch this session if you want to understand more about the guidelines for antiplatelet secondary prevention of ACS/PC and to review available data on antiplatelet therapy after ACS/PCI.
Ultrathin-strut vs. thin-strut DES for primary PCI
27 Jun 2020 – From PCR e-Course 2020
Watch this session to review the role of ultrathin DES in optimising clinical outcomes for STEMI patients, to assess the impact of the BIOSTEMI trial to daily practice and to learn about real-world challenges when treating STEMI patients.
Videos included on this page: the Hot Line presentation...
Are Lower MR Grades Within Our "Clasp"? – PASCAL Repair System Experience
Watch this session to know more about the transcatheter PASCAL Repair System for the treatment of mitral regurgitation and its clinical and commercial experience.
